![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1082, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Accutane label warns of severe skin reactions
Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Health Canada has approved fludarabine [`Fludara'; Berlex Canada] in an additional indication
Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Health Canada warns against herbal sleep supplement
Reactions Weekly, Vol. 1, Iss. 1149, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Shortclean for diabetes may be risky warns Health Canada
Reactions Weekly, Vol. 1, Iss. 1079, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Imiquimod: Severe local skin reactions: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1186, 2008-01 ,pp. :